A new study published in JAMA Ophthalmology reveals that weight loss drugs like Ozempic and similar medications could cause ...

Recent studies reveal a concerning trend of vision loss among patients using Ozempic and other weight loss products, raising ...

A recent study suggests a potential link between Ozempic and vision loss, particularly non-arteritic anterior ischemic optic ...

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.

Weight-loss drugs such as semaglutides or tirzepatides may raise patients’ risk of nonarteritic anterior ischemic optic ...

The following is a summary of “Endovascular Thrombectomy for Extracranial Internal Carotid Artery Occlusions With Large ...

Symptoms of NAION can include blurred vision, peripheral vision loss, dark spots in vision, and changes in color perception. Though the exact mechanism is not fully understood, researchers hypothesize ...

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

Following the onset of nonarteritic anterior ischemic optic neuropathy, regular stroke workup may be necessary.

MONDAY, Feb. 10, 2025 (HealthDay News) -- Yes, rare cases of vision issues have arisen in people taking popular GLP-1 weight ...

A new study from Mass Eye and Ear suggests that people taking semaglutide, a drug sold as Ozempic and Wegovy, may have a ...

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...